An Investigation into Anti-proliferative Effects of MicroRNAs Encoded by the MiR-106a-363 Cluster on Human Carcinoma Cells and Keratinocytes Using Microarray Profiling of MiRNA Transcriptomes
Overview
Affiliations
Transfection of human oral squamous carcinoma cells (clone E10) with mimics for unexpressed miR-20b or miR-363-5p, encoded by the miR-106a-363 cluster (miR-20b, miR-106a, miR-363-3p, or miR-363-5p), caused 40-50% decrease in proliferation. Transfection with mimics for miR-18a or miR-92a, encoded by the miR-17-92 cluster (all members being expressed in E10 cells), had no effect on proliferation. In contrast, mimic for the sibling miRNA-19a yielded about 20% inhibition of proliferation. To investigate miRNA involvement profiling of miRNA transcriptomes were carried out using deoxyoligonucleotide microarrays. In transfectants for miR-19a, or miR-20b or miR-363-5p most differentially expressed miRNAs exhibited decreased expression, including some miRNAs encoded in paralogous miR-17-92-or miR-106b-25 cluster. Only in cells transfected with miR-19a mimic significantly increased expression of miR-20b observed-about 50-fold as judged by qRT-PCR. Further studies using qRT-PCR showed that transfection of E10 cells with mimic for miRNAs encoded by miR-17-92 - or miR-106a-363 - or the miR-106b-25 cluster confirmed selective effect on expression on sibling miRNAs. We conclude that high levels of miRNAs encoded by the miR-106a-363 cluster may contribute to inhibition of proliferation by decreasing expression of several sibling miRNAs encoded by miR-17-92 or by the miR-106b-25 cluster. The inhibition of proliferation observed in miR-19a-mimic transfectants is likely caused by the miR-19a-dependent increase in the levels of miR-20b and miR-106a. Bioinformatic analysis of differentially expressed miRNAs from miR-106a, miR-20b and miR-363-5p transfectants, but not miR-92a transfectants, yielded significant associations to "Cellular Growth and Proliferation" and "Cell Cycle." Western blotting results showed that levels of affected proteins to differ between transfectants, suggesting that different anti-proliferative mechanisms may operate in these transfectants.
Kehl A, Valkai M, Van de Weyer A, Brockmann M, Steiger K, Schusser B Vet Sci. 2023; 10(2).
PMID: 36851429 PMC: 9966613. DOI: 10.3390/vetsci10020125.
Hu C, Huang Q, Sun Q Front Oncol. 2022; 12:852611.
PMID: 35574333 PMC: 9094482. DOI: 10.3389/fonc.2022.852611.
Wang X, Guo J, Yu P, Guo L, Mao X, Wang J J Exp Clin Cancer Res. 2021; 40(1):35.
PMID: 33478586 PMC: 7819156. DOI: 10.1186/s13046-021-01840-x.
Drobna M, Szarzynska B, Jaksik R, Sedek L, Kuchmiy A, Taghon T Cells. 2020; 9(5).
PMID: 32380791 PMC: 7290785. DOI: 10.3390/cells9051137.
MicroRNAs in ovarian follicular atresia and granulosa cell apoptosis.
Zhang J, Xu Y, Liu H, Pan Z Reprod Biol Endocrinol. 2019; 17(1):9.
PMID: 30630485 PMC: 6329178. DOI: 10.1186/s12958-018-0450-y.